Complement Therapeutics

About Complement Therapeutics

Complement Therapeutics (CTx) is a biotechnology company focused on developing innovative treatments for complement-related diseases. As a spin-out from The University of Manchester, CTx leverages world-leading expertise in the Complement System to address unmet clinical needs in diseases such as age-related macular degeneration (AMD) through novel therapeutic approaches and precision medicine platforms.

Products & Services

CTx001:An AAV-based gene therapy in pre-clinical development for the targeted treatment of Geographic Atrophy (late dry age-related macular degeneration), aiming to transform lives with a unique mechanism of action.

Systemic Complement Modulation Therapies:Therapeutics aimed at systemic modulation of the complement system to meet the needs of patients with complement-mediated diseases.

Complement Precision Medicine (CPM) Platform:A novel mass spectrometry platform enabling simultaneous measurement of complement proteins from a systemic blood sample.

Gene Therapies:Multiple gene therapy platforms being developed for complement-related diseases.

Protein Therapies:Protein-based therapeutic approaches for complement dysregulation.

Specialties

Complement System Expertise Age-Related Macular Degeneration (AMD) Geographic Atrophy Treatment Gene Therapy Protein-Based Therapies Complement Precision Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 72000000 MR: - FA: €72 million FAN: 72000000	D: 2023-04-17 FD: 2023-04-17	7 investors
2	RT: Series A T: - FT: Series A	A: 78840000 MR: - FA: €72 million FAN: 78840000	D: 2023-04-17 FD: 2023-04-17	7 investors

Series A Latest

2023-04-17

$72.0M

7 investors (Pro only)

Series A 2023-04-17

$78.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Ford

Chair

R

Rafiq Hasan

Chief Executive Officer

S

Steve Axon

Non Executive Director

D

Daniela Couto

Director

D

Dmitrij Hristodorov

Director

M

Michaël Vlemmix

Director

View 17 more team members with Pro

Unlock Full Team Directory

Recent News